REGENXBIO Inc. RGNX on Saturday shared long-term clinical trial findings for its experimental gene therapy surabgene ...

For adults with irregular corneas, a four-zone scleral lens demonstrates high effectiveness in improving visual performance, ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well tolerat ...

K8 slowed disease progression and trended towards improving visual acuity, which Inflammasome says warrants the drug’s ...

Raleigh, NC - July 20, 2026 - PRESSADVANTAGE - Porter Ophthalmology, a LASIK and refractive surgery practice located in ...

REMAIN data show MCO-010 optogenetic therapy delivered durable ~3-line vision gains in retinitis pigmentosa regardless of ...

Optiscan's first-in-human head and neck cancer imaging study has entered stage two ahead of time. The next stop is FDA ...

New real-world data from ASRS 2026 show nearly 40% of wet AMD patients go 180+ days without anti-VEGF treatment within a year ...

D-150 gene therapy enters pivotal Wet-AMD/DME trials, cutting injections up to 89%. Click for this FDMT update.

A Macon eye doctor says comprehensive exams can identify childhood vision problems that routine screenings or children ...

Cambium, a developer and manufacturer of advanced materials for defense and high-performance applications, launched SentinelOps™, a dual-use, tunable laser eye protection (LEP) and directed-energy (DE ...

A recent case report highlights a remarkably rapid anatomical recovery in a rare case of indirect solar retinopathy.